Recorded Chinese product: 黄体酮注射液黄体酮注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

黄体酮 辅料为注射用油是一种在国家药监局注册认定的药品。该药品含有黄体酮、黄体酮-78714cbe等成分。

该药品关联的活性成分包括:黄体酮Huangti Tong、黄体酮Huangti Tong。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:上海通用药业股份有限公司Chinese legal name: 上海通用药业股份有限公司。

您可以探索含有相同成分的其他药品:黄体酮-78714cbe成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 黄体酮注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 黄体酮Huangti Tong, 黄体酮Huangti Tong.

Manufacturers recorded for this product: 上海通用药业股份有限公司Chinese legal name: 上海通用药业股份有限公司.

Explore other medicines containing the same ingredient: 黄体酮 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 黄体酮注射液Recorded Chinese product: 黄体酮注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 1ml:20mg1 mL:20 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 上海通用药业股份有限公司Chinese legal name: 上海通用药业股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H31021401

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H31021401

Manufacturer

Chinese legal name: 上海通用药业股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H31021401

生产企业

上海通用药业股份有限公司(国产)

适应症

用于月经失调,如闭经和功能性子宫出血、黄体功能不足、先兆流产和习惯性流产(因黄体不足引起者)、经前期紧张综合症的治疗。

用法用量

肌内注射。
1??先兆流产,一般10-20mg,用至疼痛及出血停止;
2??习惯性流产史者,自妊娠开始,一次10-20mg,每周2-3次;
3??功能性子宫出血,用于撤退性出血血色素低于7?mg时,一日10mg,连用5天,或一日20?mg?连续3-4天;
4??闭经,在预计月经前8-10天,每日肌注10mg,共5天;或每日肌注20?mg?3-4天;
5??经前期紧张综合症,在预计月经前12天注射10-20mg,连续10天。

不良反应

偶见恶心、头晕及头痛、倦怠感、寻麻疹、乳房肿胀、长期连续应用可月经减少或闭经、肝功能异常、浮肿、体重增加等。

禁忌

严重肝损伤患者禁用(使症状恶化)。

注意事项

1.肾病、心脏病水肿、高血压的患者慎用。2.经前紧张症是否存在黄体酮缺乏尚无定论,故使用黄体酮治疗还有争议。3.对早期流产以外的患者投药前应进行全面检查,确定属于黄体功能不全再使用。

贮藏

遮光,密闭保存。

规格

1ml:20mg

证据Evidence

  • 批准文号: 国药准字H31021401
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.